AMRN FY 2025 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$183M-20.1% YoY

Gross Profit

$121M66.1% margin

Operating Income

-$14M-7.6% margin

Net Income

-$39M-21.2% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$671M

Total Liabilities

$211M

Stockholders' Equity

$459M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$183M	$229M	-20.1%
Gross Profit	$121M	$81M	+48.5%
Operating Income	-$14M	-$92M	+84.8%
Net Income	-$39M	-$82M	+52.8%